Suppr超能文献

人体骨骼中β粒子发射体的平均骨骼剂量因子。第二部分:亲表放射性核素。

Mean skeletal dose factors for beta-particle emitters in human bone. Part II: surface-seeking radionuclides.

作者信息

Spiers F W, Beddoe A H, Whitwell J R

出版信息

Br J Radiol. 1981 Jun;54(642):500-4. doi: 10.1259/0007-1285-54-642-500.

Abstract

Mean skeletal dose factors for surface-seeking beta-emitting radionuclides have been derived on the basis of the beta-particle dose factors calculated for human bones by Spiers et al. (1978b), or from empirical formulae representing these calculations given by Beddoe and Spiers (1979). The dose factors are derived for the same tissues as in Part I (Spiers et al., 1978a), namely, (1), sDM/Dskel, the mean dose to haemopoietic marrow in trabecular bone, and (2), sDs/Dskel, the mean dose to endosteal tissues lying in a zone 0-10 microns from trabecular surfaces. The dose factors are given as fractions of Dskel, the "dose to bone", calculated from the energy released by the retained radionuclide divided by the total mass of mineral bone. As in Part I, the dose factors are given for three ages, 1.7, 9 and 44 years and extrapolation to lower ages is made on the basis of calculations for a lumbar vertebra of an infant aged 3.5 weeks. The factors are given for six radionuclides covering a range of mean beta-particle energies from 0.0255 MeV (171Tm) to 0.93 MeV (90Y). The dosimetry is also considered for some radionuclides that first deposit on bone surfaces before being translocated to the bone volume. In the case of 45Ca, for example, it is shown that the dose calculation that includes both the surface and the volume depositions gives integrated doses to ten days and 100 days that are respectively 4.5 and 1.9 times the corresponding values calculated conventionally on a volume deposition only. Endosteal dose factors are similarly considered, and other radionuclides included as surface-plus-volume depositions are 47Ca, 89Sr and 90Sr + 90Y.

摘要

用于表面寻找型β发射放射性核素的平均骨骼剂量因子,是根据Spiers等人(1978b)为人体骨骼计算的β粒子剂量因子,或根据Beddoe和Spiers(1979)给出的代表这些计算的经验公式推导得出的。剂量因子是针对与第一部分(Spiers等人,1978a)相同的组织推导得出的,即:(1)sDM/Dskel,小梁骨中造血骨髓的平均剂量;(2)sDs/Dskel,位于距小梁表面0 - 10微米区域内骨内膜组织的平均剂量。剂量因子以Dskel的分数形式给出,Dskel是“骨剂量”,通过保留的放射性核素释放的能量除以矿物质骨的总质量计算得出。与第一部分一样,剂量因子针对三个年龄给出,分别为1.7岁、9岁和44岁,并根据对一名3.5周龄婴儿腰椎的计算结果外推至更低年龄。这些因子针对六种放射性核素给出,其平均β粒子能量范围从0.0255 MeV(171Tm)到0.93 MeV(90Y)。还考虑了一些首先沉积在骨表面然后再转移到骨体积内的放射性核素的剂量学。例如,对于45Ca,结果表明,包括表面沉积和体积沉积的剂量计算得出的10天和100天的累积剂量,分别是仅基于体积沉积的传统计算值的4.5倍和1.9倍。同样考虑了骨内膜剂量因子,作为表面加体积沉积包括在内的其他放射性核素还有47Ca、89Sr和90Sr + 90Y。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验